Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of NK-1 receptor antagonists for treating major depressive disorders

Use of NK-1 receptor antagonists for treating major depressive disorders

US Patent 6613765 · Granted Sep 2, 2003

Estimated economic value: $134,242,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical compounds2025
Structural support system for rockwork with mechanical fastening of adjacent chi2025
ROR1-specific antigen binding molecules2025
4-hydroxypiperidine derivatives and their use as inhibitors of ubiquitin specifi2023
Substituted pyrrolo[2,3-d]pyrimidines as Bruton's Tyrosine Kinase inhibitors2023
3-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide2023
Substituted azaindoline derivatives as NIK inhibitors2022
Cyanoindoline derivatives as NIK inhibitors2021
Substituted cyanoindoline derivatives as NIK inhibitors2021
Heteroaromatic derivatives as NIK inhibitors2021
Pharmaceutical compounds2021
6-membered heteroaromatic substituted cyanoindoline derivatives as NIK inhibitor2021